Relationship between Covid-19-associated pneumonia severity with coagulopathy and mortality

dc.contributor.authorAvci, Begum Seyda
dc.contributor.authorKaya, Adem
dc.contributor.authorSumbul, Hilmi Erdem
dc.contributor.authorIcme, Ferhat
dc.contributor.authorYesilagac, Hasan
dc.contributor.authorUnal, Nevzat
dc.contributor.authorYesiloglu, Onder
dc.contributor.authorCinar, Hayri
dc.contributor.authorTurunc, Tuba
dc.date.accessioned2022-08-16T10:49:51Z
dc.date.available2022-08-16T10:49:51Z
dc.date.issued2021
dc.description.abstractPurpose: In the present study, the possibility of predicting mortality with the change in coagulation parameters depending on the severity of Covid-19-associated pneumonia was investigated. Materials and Methods: A total of 137 patients with Covid-19-associated pneumonia were included in the study. The patients were divided into three groups according to the severity of pneumonia as mild, moderate and severe. According to the severity of pneumonia, the parameters of complete blood count and the levels of biochemical parameters were compared between the groups. By examining blood parameters according to mortality, ROC analysis and regression analysis were performed to determine the net effect of these parameters on mortality. Results: As the severity of pneumonia increased, Prothrombin time (PT), International normalized ratio (INR) and Activated partial thromboplastin time (aPTT) values were also increased, and a statistically significant difference was found between the groups in PT and INR values. PT, INR and aPTT levels were higher in cases with mortality. Mortality can be predicted with 93.5% sensitivity and 97.5% specificity. according to the >45.1 seconds(sec) cut-off value of the coagulation parameter (aPTT +PT. Conclusion: The coagulation parameter (aPTT + PT), whose level increases secondarily to the increase in Covid-19-associated pneumonia severity, provides successful results in predicting mortality, and may be a parameter that we can recommend in clinical use.en_US
dc.identifier.endpage547en_US
dc.identifier.issn2602-3032en_US
dc.identifier.issue2en_US
dc.identifier.startpage540en_US
dc.identifier.urihttps://dergipark.org.tr/en/download/article-file/1518997
dc.identifier.urihttp://hdl.handle.net/11727/7362
dc.identifier.volume46en_US
dc.identifier.wos000694865200017en_US
dc.language.isoengen_US
dc.relation.isversionof10.17826/cumj.864023en_US
dc.relation.journalCUKUROVA MEDICAL JOURNALen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergien_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectCovid-19 infectionen_US
dc.subjectcoagulationen_US
dc.subjectPTen_US
dc.subjectINRen_US
dc.subjectaPTTen_US
dc.subjectmortalityen_US
dc.titleRelationship between Covid-19-associated pneumonia severity with coagulopathy and mortalityen_US
dc.typearticleen_US

Files

Original bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
ds72.pdf
Size:
276.69 KB
Format:
Adobe Portable Document Format
Description:

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: